US · Healthcare

WuXi Biologics (Cayman) Inc (WXXWY)

Biotechnology

WuXi Biologics (Cayman) Inc (WXXWY) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for WXXWY

P/E ratio

25.00

WuXi Biologics (Cayman) Inc (WXXWY) — FAQ

What is WXXWY's P/E ratio?

The price-to-earnings (P/E) ratio for WuXi Biologics (Cayman) Inc (WXXWY) is 25.00 (data as of 2026-05-24).

Does WuXi Biologics (Cayman) Inc pay a dividend?

Dividend yield is not available in the current snapshot for WuXi Biologics (Cayman) Inc (WXXWY). Check the MyAverix Finance app for the latest dividend data.

What sector is WuXi Biologics (Cayman) Inc in?

WuXi Biologics (Cayman) Inc (WXXWY) is classified in the Healthcare sector (Biotechnology industry).

What exchange is WXXWY listed on?

WXXWY is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)